Mark A. Morgan, MD, discusses the role of robotic surgery in gynecologic cancer.
Mark A. Morgan, MD
Advertisement
Articles by Mark A. Morgan, MD
Mark A. Morgan, MD, professor of obstetrics and gynecology, University of Pennsylvania, director, Gynecology Oncology for University of Pennsylvania Health Systems, discusses bulk reduction surgery prior to chemotherapy in patients with stage III ovarian cancer.
Advertisement
Latest Updated Articles
Bulk Reduction Surgery in Stage III Ovarian CancerPublished: October 21st 2013 | Updated:
The Role of Robotic Surgery in Gynecologic CancerPublished: November 1st 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
